Caffeine and Prophylactic Noradrenaline Requirement During Cesarean Delivery
Condition(s) studied
Investigational drug(s) / intervention(s)
Caffeine (200 mg): Patients will receive 200 mg oral caffeine 30 minutes before spinal anesthesia
Placebo: Patient will receive placebo capsule
Study summary
Spinal anesthesia is the preferred regional technique in obstetric practice because it provides high maternal satisfaction and eliminates the need for airway manipulation. Despite these advantages, it is frequently complicated by spinal anesthesia-induced hypotension , defined as a reduction in systolic blood pressure of more than 20% from baseline or an absolute SBP below 100 mmHg. Spinal hypotension can have serious consequences, including maternal hypoperfusion that may lead to neurological or renal dysfunction, as well as fetal acidosis and bradycardia, which can compromise neonatal outcomes. The present study aims to evaluate the effect of preoperative caffeine administration on noradrenaline requirements during spinal anesthesia in obstetric patients. Specifically, the objectives are to compare noradrenaline requirements between the study groups and to assess the incidence of hypotension in both groups.
Eligibility
Primary outcome measure(s)
- Average noradrenaline requirement — After spinal anesthesia till delivery
The total noradrenaline administered as an infusion plus boluses divided by patient weight and infusion time.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Cairo University Hospitals | Cairo | Egypt |
More Cairo University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07655245 on ClinicalTrials.gov ↗ ← All trials in Egypt